Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c02654 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Laura Castillo-Ribelles und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Tandem Mass Spectrometry, Glucosylceramides, Galactosylceramides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundaci?n BBVA, European Regional Development Fund, 'la Caixa' Foundation.
Abstract (Originalsprache)
Mutations in GBA1, encoding glucocerebrosidase beta 1 (GCase), are the most common genetic risk factor for Parkinson's disease (PD). GCase dysfunction leads to an accumulation of glucosylceramide (GluCer) substrates in different organs and fluids. Despite the challenges in quantifying GluCer isoforms in biological samples, their potential clinical interest as PD biomarkers justifies the development of robust assays. An extensively evaluated high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for quantifying 14 GluCer and galactosylceramide (GalCer) isoforms in human cerebrospinal fluid (CSF) samples is presented. Sample pretreatment, HPLC, and MS/MS parameters were optimized. Evaluation was performed according to the recommendations of the Clinical and Laboratory Standards Institute and European Medicines Agency guidelines. Four 7-point calibration curves were generated, with a linearity interval from 2.5 to 200 nM (R2 ≥ 0.995). The limit of quantification was set at 5 nM. Between-run precision and accuracy were up to 12.5 and 9%, respectively. After method validation, we measured the levels of GluCer and GalCer isoforms in CSF human samples, including 6 healthy controls (HC), 22 idiopathic GBA1 wild-type PD (iPD) patients, and 5 GBA1-associated PD (PD-GBA) patients. GluCer/GalCer median ratios were found to be higher in the CSF of PD-GBA patients, particularly in severe GBA1 mutations, than those in iPD and HC. The observed trends in GluCer/GalCer ratios among groups provide novel information for the comprehensive analysis of sphingolipids as potential biomarkers of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.
- Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.
- Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 0…
- Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.
- Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London WC1N 3BG, U.K.
ORCID-Profile: Laura Castillo-Ribelles, Marta Martinez-Vicente, Clara Carnicer-Caceres
Förderung
- Fundaci?n BBVA
- European Regional Development Fund
- 'la Caixa' Foundation
- Instituto de Salud Carlos III
Zitieren
APA
Castillo-Ribelles, L., Arranz-Amo, J. A., Hernández-Vara, J., Samaniego-Toro, D., Enriquez-Calzada, S., Pozo, S. L., Camprodon-Gomez, M., Laguna, A., Arrúe-Gonzalo, M., Ferrer, R., Martinez-Vicente, M., & Carnicer-Caceres, C. (2024). Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c02654
Vancouver
Castillo-Ribelles L, Arranz-Amo JA, Hernández-Vara J, Samaniego-Toro D, Enriquez-Calzada S, Pozo SL, et al. Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c02654
BibTeX
@article{CastilloRibelles2024,
author = {Castillo-Ribelles, Laura and Arranz-Amo, Jose Antonio and Hernández-Vara, Jorge and Samaniego-Toro, Daniela and Enriquez-Calzada, Silvia and Pozo, Sara Lucas-Del and Camprodon-Gomez, Maria and Laguna, Ariadna and Arrúe-Gonzalo, Mercedes and Ferrer, Roser and Martinez-Vicente, Marta and Carnicer-Caceres, Clara},
title = {Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c02654}
}
EUVIMED